524 Ypt/Rab-GAP domain of gyp1p-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Mixed metal/non-metal compounds | 2 | 0.1 | 24× | not tested | |
| Nucleosides, nucleotides, and analogues | 2 | 1.1 | 1.83× | not tested | |
| Organic oxygen compounds | 1 | 0.8 | 1.27× | not tested | |
| Homogeneous non-metal compounds | 1 | 0.9 | 1.18× | not tested | |
| Homogeneous metal compounds | 2 | 1.9 | 1.03× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04315 | GDP | Guanosine-5'-Diphosphate | 6 |
| DB03401 | I3P | 1D-myo-inositol 1,4,5-trisphosphate | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| UNX | UNKNOWN ATOM OR ION | 15 |
| BEF | BERYLLIUM TRIFLUORIDE ION | 6 |
| GDP | GUANOSINE-5'-DIPHOSPHATE | 6 |
| I3P | D-MYO-INOSITOL-1,4,5-TRIPHOSPHATE | 2 |
| MGmetal | MAGNESIUM ION | 2 |
| AF3 | ALUMINUM FLUORIDE | 1 |
| CL | CHLORIDE ION | 1 |